文献速递系统性红斑狼疮

LUPIN:系统性红斑狼疮患者自评工具的开发与验证

Development and validation of LUPIN: a patient-centred self-administered tool to assess disease activity and patient-reported outcomes in systemic lupus erythematosus.
PubMed 文献 · RMD Open · 2025-09-23

LUPIN 是一个由患者与狼疮专家共同设计的自评问卷,用于评估系统性红斑狼疮(SLE)疾病活动度和患者报告结局。研究在法国本土及海外34个中心发放问卷,444例参与者完成,LUPIN 与 SLEDAI/PhGA 相关性显著但较弱(r<0.39),与 SF-36 疲劳、疼痛、躯体功能域相关性较强(r=0.65、0.65、0.69);在活动性 SLE(SLEDAI≥4,n=153)中与临床 SLEDAI 相关性提高(r=0.53,p<0.0001)。

要点

  • LUPIN 与医生评估的 SLEDAI/PhGA 相关性显著但较弱(r<0.39)。
  • LUPIN 与 SF-36 疲劳(r=0.65)、疼痛(r=0.65)、躯体功能(r=0.69)相关性较强。
  • 活动性 SLE(SLEDAI≥4,n=153)中 LUPIN 与临床 SLEDAI 相关性 r=0.53,p<0.0001。

核心结论

  • LUPIN 能有效捕捉传统临床指标常未充分体现的症状域,反映 SLE 患者的疾病负担。
  • LUPIN 是一个实用、可扩展的工具,可支持患者参与、共享决策和个体化疾病监测。
  • 一项纵向数字化研究正在进行,以进一步评估其追踪疾病随时间波动的价值。

研究设计与样本

  • LUPIN 与 SF-36 问卷在法国本土及海外领地34个中心发放,患者在就诊前完成问卷。
  • 医生对患者回答设盲,使用 SLEDAI-2K 和 PhGA 评估疾病活动度,并分析患者与医生评估之间的相关性和不一致性。
  • 共纳入444例参与者(85%为女性,平均年龄45岁)。

主要发现

  • 最常见表现为关节受累(86%)和皮肤受累(72%),35%有狼疮肾炎病史。
  • LUPIN 评分与 SLEDAI/PhGA 相关性有统计学意义但较弱(r<0.39)。
  • LUPIN 与 SF-36 疲劳域 r=0.65、疼痛域 r=0.65、躯体功能域 r=0.69,相关性较强。
  • 活动性 SLE 患者(SLEDAI≥4,n=153)中 LUPIN 与临床 SLEDAI 相关性提高(r=0.53,p<0.0001)。
  • 不一致性主要由患者报告的疲劳和疼痛驱动,与疑似的机械性或中枢性疼痛综合征无关。

临床怎么用

  • LUPIN 可支持患者参与、共享决策和个体化疾病监测。
  • 原文结论未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop and validate LUPIN, a self-administered, patient-centred questionnaire codesigned by patients and lupus specialists to assess disease activity and patient-reported outcomes in systemic lupus erythematosus (SLE). METHODS: LUPIN and the SF-36 questionnaires were distributed across 34 centres in both metropolitan France and overseas territories. Patients completed the questionnaire prior to their consultations. Physicians, blinded to patients' responses, assessed disease activity using SLE Disease Activity Index 2000 (SLEDAI-2K) and Physician Global Assessment (PhGA). Correlations and discordances between patient and physician assessments were analysed. RESULTS: Among 444 participants (85% women, mean age 45 years), the most common manifestations included joint (86%) and skin (72%) involvement; 35% had a history of lupus nephritis. While correlations between LUPIN scores and SLEDAI/PhGA were statistically significant but modest (r<0.39), stronger associations were observed with SF-36 domains for fatigue (r=0.65), pain (r=0.65), and physical function (r=0.69). In patients with active SLE (SLEDAI≥4; n=153), the correlation between LUPIN and clinical SLEDAI improved (r=0.53, p<0.0001). Discordances were primarily driven by patient-reported fatigue and pain, unrelated to suspected mechanical or central pain syndromes. CONCLUSION: LUPIN effectively captures symptom domains that are often under-represented in conventional clinical indices and reflects the lived burden of disease in SLE. It offers a practical, scalable tool to support patient engagement, shared decision-making and individualised disease monitoring. A longitudinal digital study is underway to further assess its value in tracking disease fluctuations over time.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Scherlinger M, Kleinmann JF, Folliasson A, et al. Development and validation of LUPIN: a patient-centred self-administered tool to assess disease activity and patient-reported outcomes in systemic lupus erythematosus. RMD Open. 2025. PMID: 40992789. doi:10.1136/rmdopen-2025-006106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。